Al-Khodari Sons, Gulf Pharmaceutical, Sanad: Gulf Equity Preview
The following stocks may rise or fall in Persian Gulf markets. Stock symbols are in parentheses and prices are from the last close.
Saudi Arabia’s Tadawul All Share Index (SASEIDX) fell the most in two weeks, losing 2.6 percent to 5,931.29. Dubai’s DFM General Index (DFMGI) climbed less than 0.1 percent, while Abu Dhabi’s ADX General Index (ADSMI) slid less than 0.1 percent.
Abdullah A.M. Al-Khodari Sons Co. (ALKHODAR) : The Saudi Arabian contracting company signed a contract valued at 24 million riyals ($6.4 million) with the Ministry of Municipal and Rural Affairs to develop a cleaning project in Skaka city. The shares dropped 1.6 percent to 62.75 riyals.
Gulf Pharmaceutical Industries (JULPHAR UH): The United Arab Emirates-based medical drugs and supplies producer known as Julphar plans to build a $26 million factory in Algeria. The shares were unchanged at 2.15 dirhams.
Sanad Cooperative Insurance & Reinsurance Co. (SANAD) : The Saudi Arabian insurer named Philip William Head as its new chief executive officer. The shares slumped 3.4 percent to 14.15 riyals.
To contact the reporter on this story: Mourad Haroutunian in Riyadh at mharoutunian@bloomberg.net
To contact the editor responsible for this story: Shaji Mathew at shajimathew@bloomberg.net
Rate this Page
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.